Pharmaceutical company Inotiv has notified the US Securities and Exchange Commission (SEC) that its business operations took a hit after hackers compromised and encrypted its internal systems. The incident, the organization said in a Form 8-K filing, occurred on 08 August 2025, and prompted Inotiv to initiate containment and remediation processes. “The company’s preliminary investigation determined that a threat actor gained unauthorized access to, and encrypted certain of, the company’s system
inotiv (2)
A ransomware attack has forced drug research firm Inotiv to shut down critical systems, resulting in operational disruptions. Inotiv is an analytical drug discovery and development service that works with various pharmaceutical companies. It employs over 2,000 research specialists and reports an annual revenue of over $500 million. According to a regulatory filing with the US Securities and Exchange Commission (SEC), Inotiv discovered the cyber attack on 8 August. “On August 8, 2025, Inotiv,
